: Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. The Journal of experimental medicine 1989,170(1):145–161.CrossRefPubMed 30. Lebedev AA, Krause MH, Isidro AL, Vagin AA, Orlova EV, Turner J, Dodson EJ, Tavares P, Antson AA: Structural framework for DNA translocation via the
viral portal protein. The EMBO journal 2007,26(7):1984–1994.CrossRefPubMed Authors’ contributions JFY, SJZ and OJ performed see more the microarray experiments. RAF and OEC contributed towards the data analysis. GHZ carried out animal experiments and sample collection. CAS and NAA contributed intellectually to the study, and to manuscript preparation. All authors have read and approved the final manuscript.”
“Background One of the basic physiological functions of the resident microbiota is that it functions as a microbial barrier against pathogens [1]. A healthy, balanced microbiota has been suggested to be predominantly saccharolytic, with significant numbers of bifidobacteria and lactobacilli [2]. The use of pre- and probiotics has thus been suggested as approaches to prevent Salmonella infections and infections by enteric pathogens in general [3–5]. Prebiotics were originally defined
as “”non-digestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon, and thus improve host health”" [6]. The main candidates that meet the required criteria for classification of a food ingredient as a prebiotic are fructo-oligosaccharides, including CCI-779 price inulin, galacto-oligosaccharides and lactulose [7]. Numerous studies have shown that prebiotics stimulate the growth of bifidobacteria and lactobacilli in vivo [8–12] and specific strains from these genera have been shown to suppress bacterial infections including those caused by ingestion of Salmonella enterica serovar Typhimurium
(S. Typhimurium) [13–17]. Mechanisms proposed to explain the enhanced resistance to pathogens induced by lactobacilli and bifidobacteria include Methocarbamol (i) competitive inhibition of the epithelial and mucosal adherence of pathogens, (ii) production of antimicrobial substances, (iii) immune modulation, and (iv) production of short chain fatty acids which can reduce the growth of acid-sensitive pathogens like Salmonella [1, 18, 19]. Salmonella infections are a global problem with Salmonella enterica serovar Typhi (S. Typhi) and serovar Paratyphi (S. Paratyphi) causing epidemics of severe systemic infections in developing countries [20, 21]. S. Typhi and S. Paratyphi do not cause systemic infections in other mammalian hosts than humans, but the BALB/c mouse model used in the present study provides a murine model of human typhoid fever [22]. In the EU, Salmonella enterica serovar Enteritidis (S. Enteritidis) and S.
Related posts:
- 24, 25 and 26 Anaemia and drug resistance, but not hepatomegaly,
- The study protocol was approved by the ethics committee of the He
- Bifidobacteria are a regular component of human and animal gut mi
- Mean TER values did not differ after 1-3 h of incubation (P > 0 0
- , 1987 and Bento and Miniti, 1989), but full functional recovery